Replies to post #516283 on NorthWest Biotherapeutics Inc (NWBO)

[no2koolaid]

flip, if memory serves, you indicated you had interest in policy. Have you seen this?

Based on research out of the University of Chicago (Philipson, et al), it was found that some cancer patients would miss out on treatment due to the Inflation Reduction Act's price controls.

Obviously, such a concern would be for all novel drugs but most immediate of concerns for investors is the threat to NWBO pricing an approved DCVax in the US.

Also, as you know, there are a series of issues with pricing in the EU, as each country effectively negotiates its own deal, irrespective of a broad EMA approval.

Thoughts?